03:07
2026-08-04
insideai.news
artificial-intelligence
Pathos AI Licenses Breast Cancer Drug from China’s Alphamab for $125M
Pathos AI, a New York City-based AI-driven drug development company, agreed to license the experimental breast cancer drug JSKN016 from China's Jiangsu Alphamab Biopharmaceutical for an upfront paymen…